featured-image

, /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: ), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has entered into a five-year term loan facility for up to $225,000,000 (the "Credit Facility" or the "Financing") with Silver Point Finance, the direct lending business of Silver Point Capital, L.P.

The Financing consists of (i) an initial term loan facility in an aggregate principal amount of (the "Initial Facility") and (ii) a delayed draw term loan facility (the "Delayed Draw Facility") in an aggregate principal amount of . The Credit Facility closed on (the "Closing Date"), and Health Catalyst borrowed of the Initial Facility (constituting the entire amount thereof) on the Closing Date. The Delayed Draw Facility remained undrawn as of the Closing Date.



Health Catalyst has the option to draw (x) up to under the Delayed Draw Facility at any time on or prior to the date that is six months after the Closing Date, and (y) up to an additional under the Delayed Draw Facility at any time on or prior to the date that is 18 months after the Closing Date, in each case subject to certain terms and conditions. The net proceeds of the Initial Facility, together with cash on hand, will be used (x) to refinance Health Catalyst's existing convertible notes, which mature in 2025, at any time at or prior to maturity, and (y) for working capital and general corporate purposes. The proceeds of .

Back to Health Page